Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction

LCZ696 (sacubitril/valsartan) can lower the risk of cardiovascular events in chronic heart failure. However, it is unclear whether LCZ696 can improve prognosis in patients with acute myocardial infarction (MI). The present study shows that LCZ696 can prevent cardiac rupture after MI, probably due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Masanobu, Kaikita, Koichi, Sato, Koji, Sueta, Daisuke, Fujisue, Koichiro, Arima, Yuichiro, Oimatsu, Yu, Mitsuse, Tatsuro, Onoue, Yoshiro, Araki, Satoshi, Yamamuro, Megumi, Nakamura, Taishi, Izumiya, Yasuhiro, Yamamoto, Eiichiro, Kojima, Sunao, Kim-Mitsuyama, Shokei, Ogawa, Hisao, Tsujita, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
PRECLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059351/
https://www.ncbi.nlm.nih.gov/pubmed/30062181
http://dx.doi.org/10.1016/j.jacbts.2017.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059351/
https://www.ncbi.nlm.nih.gov/pubmed/30062181
http://dx.doi.org/10.1016/j.jacbts.2017.08.001

Ejemplares similares